Caribou Biosciences, Inc.CRBUNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank67
3Y CAGR+10.0%
5Y CAGR+26.0%
Year-over-Year Change
Research and development spending
3Y CAGR
+10.0%/yr
Annual compound
5Y CAGR
+26.0%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
3.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $109.44M | -15.9% |
| 2024 | $130.15M | +16.1% |
| 2023 | $112.08M | +36.3% |
| 2022 | $82.23M | +57.4% |
| 2021 | $52.26M | +51.8% |
| 2020 | $34.42M | +45.7% |
| 2019 | $23.64M | - |